Instructional Course - Requires Course Pass or Individual Course Ticket, Additional Registration Required
Abraham Morgentaler, MD
Harvard Medical School
This course will introduce and review new concepts and areas of controversy in the exciting and rapidly evolving field of testosterone therapy. The goal is to provide the attendee with a forward-looking and practical approach to diagnosis and management of the testosterone-deficient man. Topics to be addressed include: who is a candidate for T therapy; how to choose between multiple treatment options; T therapy in men with prostate cancer; the Saturation Model; effect of testosterone on general health issues, including glycemic control, metabolic syndrome, obesity, longevity; role of bone density assessment; monitoring of men on T therapy; discussion of real and alleged risks, including cardiovascular risk and sleep apnea. The material would include:
-The debate on terminology (testosterone therapy vs TRT, testosterone deficiency vs late-onset hypogonadism, etc) -Impact of testosterone therapy on obesity and metabolic conditions -In-depth review of cardiovascular data, including possibility for cardiovascular benefits -In-depth review of data regarding prostate cancer and LUTS -Use of testosterone therapy in men with a history of prostate cancer -Data regarding use of testosterone therapy in men with other conditions, including inflammatory bowel disease
In addition, we will include a section of challenging clinical cases/scenarios, such as the use of testosterone therapy in men with elevated PSA after negative biopsy, and management of complications from treatment.